DARE TO BE DIFFERENT

CyberFreight Pharmalogistics is a privately owned company, founded in 1999. With three locations in the Rotterdam Port Area, as well as two locations at Amsterdam Schiphol Airport, and over 50 employees,
CyberFreight has grown into a reputable, well known,  high quality logistic service provider. The customer is always at the center of the business.

DARE TO BE DIFFERENT

SERVICES

  • GDP compliant Airfreight import and export
  • GDP compliant Sea freight import and export
  • GDP compliant storage 15-25 degrees Celsius
  • GDP compliant storage 2-8 degrees Celsius
  • GDP compliant European Distribution, dedicated and non-dedicated
  • Active and passive packing solutions,also on customer site
  • Handling clinical trials


DARE TO BE DIFFERENT

STORAGE FACILITY

  • Brand new modern facility within
  • Schiphol Airport Area
  • Fully GDP compliant and certified
  • Floorheated and airconditioned
  • for excursion-free temperature management
  • Wholesales license
  • TAPA level security


DARE TO BE DIFFERENT

SERVICES

CERTIFICATIONS

  • CEIV IATA certified
  • GDP certified
  • ISO-9001 certified
  • ISO-14001 certified
  • AEO certified


DARE TO BE DIFFERENT

CONTACT

Willem Lodder
Director Business Development
CyberFreight Pharmalogistics
Markkaweg 1, 2153NB, Nieuw-Vennep, The Netherlands
Tel: +31 (0)88 – 1014 702
Mob: +31 (0)6 202 55 714
Email: willemlodder@cyberfreight.nl


Go to article: Home | Cracking Alzheimer'sGo to article: In This IssueGo to article: Scandinavian Healthcare Limited Company InsightGo to article: Scandinavian Healthcare LimitedGo to article: ContentsGo to article: DJAGo to article: NewsGo to article: Where are the world's pharma manufacturing hotspots?Go to article: Bea TechnologiesGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Is a universal flu vaccine on horizon?Go to article: MicronovaGo to article: The racemisation risk: new tool could identify drugs destined to failGo to article: BioassayGo to article: Shooting up: what does the future hold for growth drugs?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: Could a new antibody screening method lead to better drugs?Go to article: AlpexGo to article: EventsGo to article: Event: CPhI ChinaGo to article: AbiogenGo to article: Next IssueGo to article: MoehsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Novo NordiskGo to article: Pharma Support ServicesGo to article: CyberfreightGo to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Brooks Automation IncGo to article: EcocoolGo to article: ZenatekGo to article: Miami International AirportGo to article: AirBridgeCargoGo to article: AirBridgeCargo Company InsightGo to article: SkycellGo to article: G.F.Go to article: BaxterGo to article: BrukerGo to article: EmisphereGo to article: SephaGo to article: raPHARMGo to article: Sanofi